The UK has seen a drop in Medical Affairs recruitment, whilst hiring in the EEA has grown. What have been the specific trends by country? Which regions in the UK have been strongest?
Read our recent report to find out.
Written in partnership with CPL Life Sciences, this report examines key trends within Medical Affairs recruitment; compares last year’s hiring levels with the pace of recruitment in early 2022; and compares the hiring activity of the top organisations.
For labour market insights and the trends that drove Medical Affairs recruitment so far in 2022, Download the report now!
Latest reports
Year in Review – UK Tech Labour Market Trends Report, January 2026
This report highlights that the UK technology labour market grew in 2025 despite a cautious economic environment, with IT vacancies rising by about 15% year-on-year and London accounting for nearly 45% of national demand. It also shows strong growth in fintech and product management roles—especially in London—while banks, consultancies, and digital transformation projects increasingly drove demand for IT professionals.
Year in Review – UK Legal Labour Market Trends, January 2026
UK legal hiring grew modestly in 2025, with vacancies rising 1.4%, but strong demand in specialist areas drove large increases in personal injury (+30.3%), banking and finance (+23.4%), and tax (+19%) roles. Regional markets expanded alongside London, with the North East (+28.6%) and Wales (+26%) leading growth, while law firm recruitment strategies diverged sharply, with some firms rapidly expanding and others scaling back hiring.
Year in Review – Life Sciences Report
This report finds that UK life sciences hiring cooled in 2025 as companies prioritised funding discipline and cash efficiency, with scientific vacancies falling 7% overall despite continued strength in core hubs such as London and growth in South East England. While regional trends diverged—most notably rapid expansion in North East England—major employers such as Roche, Lonza, and Johnson & Johnson increased hiring, even as recruitment slowed at firms including GSK and AstraZeneca.
